Trance away the pain While how it works is not fully understood, hypnosis shows potential for being part of a multi-pronged pain management approach. 360info · Dec 11, 2022
Cannabis for pain: A scientist reveals how weed activates our body's opioid system Marijuana may offer an alternative to pain management, as the compounds in cannabis activate the body's own opioid system, a neuropharmacologist explains. Inverse · Nov 12, 2022
Cannabis holds promise for pain management, reducing the need for opioid painkillers – a neuropharmacology expert explains how Drug overdose deaths from opioids continue to rise in the U.S. as a result of both the misuse of prescription opioids and the illicit drug market. The Conversation · Nov 2, 2022
Medical cannabis could be better alternative to opioids in managing pain: Study A new study of thousands of patients has concluded that medical cannabis could be an important alternative to opioids for pain management. Read more on Dynamite News: Dynamite News · Sep 28, 2022
Scratching the ‘itch’ behind pain management UK-based geneticist delivers talk at Genome Foundation’s webinar The Hindu · Aug 22, 2022
Care home where residents 'at risk of pain and neglect' could be shut down as it remains in special measures Stamford House, in Rochdale, is still 'inadequate' in several areas - including infection control, pain management and nutrition - according to the latest inspection report by the Care Quality Commission (CQC). Manchester Evening News · Aug 15, 2022
Former NFL Star Ricky Williams: Players Have Been Using Cannabis To Treat Pain For Decades As the stigma around cannabis steadily fades, more and more professional athletes are opening up about its use cases, specifically as a natural remedy for pain management. Some of these athletes became cannabis entrepreneurs themselves. Benzinga · Jul 19, 2022
Bill Clinton Says CBD Shows Promising Results As Alternative To Opioids For Pain Management Former President Bill Clinton stated Tuesday that&n Benzinga · Jul 13, 2022
Psychedelics Company Nabs Health Canada Construction Permit, Find Out How They Got It Canadian life sciences company Nirvana Life Sciences Inc. (CSE: NIRV), focused on research & development of non-addictive pain management and relapse prevention products for pain and addictions, has been granted approval to build its R&D facility in Vancouver by Canada’s governmental department of Health. Benzinga · Jun 29, 2022
Addiction Relapse Prevention: Nirvana Pre-Clinical Study Suggests Psilocybin Could Help Heroin Addiction Nirvana Life Sciences Inc. (CSE: NIRV) is a Canadian-based life sciences company that develops novel therapeutic products derived from psychedelics to produce non-addictive solutions for opioid addiction treatment and ongoing pain management. Nirvana has recently joined forces with Integrative Therapy Discovery (ITD) Labs of Italy. Benzinga · Jun 3, 2022
The NFL's Recent Investment in Cannabis Signals an Important Evolution in Its Approach to Preventing and Treating Sports Injuries By Dr. Michael D. Lewis, MD, MPH, Colonel (Retired), U.S. Army, and CV Sciences Medical Advisor Benzinga · Jun 3, 2022
Calls for better pain management for women choosing IUD as contraception Every year, thousands of women in Australia choose an IUD as a form of contraception but many, like Jess Holmes, say they were unprepared for the pain associated with the procedure and more needs to be done. ABC News · May 29, 2022
Why AcelRx Pharma Shares Are Trading Higher Today? The FDA has recently modified the AcelRx Pharmaceuticals Inc's (NASDAQ:ACRX) Dsuvia Risk Evaluation and Mitigation Strategies (REMS) requirements for healthcare setting audits. The Dsuvia REMS program aims to mitigate the risk of respiratory depression resulting from accidental exposure by ensuring that DSUVIA is dispensed only to patients in certified medically supervised healthcare settings. In… Benzinga · May 19, 2022
EXCLUSIVE: Bexson Biomedical's CSO Says Subcutaneous Ketamine Could Treat Wide Range Of Health Issues Bexson Biomedical recently signed a deal with the Stevanato Group to develop a subcutaneous delivery system of ketamine. Benzinga · May 18, 2022
Benzinga · Apr 28, 2022 EXCLUSIVE: Bexson Biomedical Inks Agreement With Stevanato For Delivery System Of Ketamine In Pain Management Bexson Biomedical, a private company in the psychedelics space, has inked a new agreement with Stevanato Group, an Italian-based provider of drug delivery solutions.
The Conversation · Apr 27, 2022 Patients leaving hospital sometimes need opioids. Doctors can reduce risks of long-term use and dependence Hospital patients are often given strong, opioid pain medicines when discharged home after surgery and other treatments. This can sometimes lead to long-term use and dependence.